Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.20.4
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance, beginning at Sep. 30, 2019 $ 1,708 $ 36,201,758 $ (26,174,082) $ 10,029,384
Balance, beginning, shares at Sep. 30, 2019 17,077,873      
Stock-based compensation expense   1,504,226   1,504,226
Net loss     (4,505,550) (4,505,550)
Balance, ending at Dec. 31, 2019 $ 1,708 37,705,984 (30,679,632) 7,028,060
Balance, ending, shares at Dec. 31, 2019 17,077,873      
Balance, beginning at Sep. 30, 2020 $ 2,315 74,850,935 (43,558,602) $ 31,294,648
Balance, beginning, shares at Sep. 30, 2020 23,154,084     23,154,084
Stock-based compensation expense $ 0 1,176,585 0 $ 1,176,585
Issuance of restricted stock for services (in shares) 1,931      
Exercise of stock options $ 2 112,444   $ 112,446
Exercise of stock options (in shares) 21,576     21,576
Net loss $ 0 0 (4,066,431) $ (4,066,431)
Balance, ending at Dec. 31, 2020 $ 2,317 $ 76,139,964 $ (47,625,033) $ 28,517,248
Balance, ending, shares at Dec. 31, 2020 23,177,591     23,177,591